IBDEI1I6 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24309,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,24309,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,24310,0)
 ;;=E11.51^^82^1051^11
 ;;^UTILITY(U,$J,358.3,24310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24310,1,3,0)
 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/o Gangrene
 ;;^UTILITY(U,$J,358.3,24310,1,4,0)
 ;;=4^E11.51
 ;;^UTILITY(U,$J,358.3,24310,2)
 ;;=^5002650
 ;;^UTILITY(U,$J,358.3,24311,0)
 ;;=E11.52^^82^1051^10
 ;;^UTILITY(U,$J,358.3,24311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24311,1,3,0)
 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,24311,1,4,0)
 ;;=4^E11.52
 ;;^UTILITY(U,$J,358.3,24311,2)
 ;;=^5002651
 ;;^UTILITY(U,$J,358.3,24312,0)
 ;;=E11.620^^82^1051^4
 ;;^UTILITY(U,$J,358.3,24312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24312,1,3,0)
 ;;=3^DM Type 2 w/ Diab Dermatitis
 ;;^UTILITY(U,$J,358.3,24312,1,4,0)
 ;;=4^E11.620
 ;;^UTILITY(U,$J,358.3,24312,2)
 ;;=^5002655
 ;;^UTILITY(U,$J,358.3,24313,0)
 ;;=I10.^^82^1052^1
 ;;^UTILITY(U,$J,358.3,24313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24313,1,3,0)
 ;;=3^Essential/Primary Hypertension
 ;;^UTILITY(U,$J,358.3,24313,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,24313,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,24314,0)
 ;;=I11.0^^82^1052^12
 ;;^UTILITY(U,$J,358.3,24314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24314,1,3,0)
 ;;=3^Hypertensive Heart Disease w/ Heart Failure
 ;;^UTILITY(U,$J,358.3,24314,1,4,0)
 ;;=4^I11.0
 ;;^UTILITY(U,$J,358.3,24314,2)
 ;;=^5007063
 ;;^UTILITY(U,$J,358.3,24315,0)
 ;;=I11.9^^82^1052^13
 ;;^UTILITY(U,$J,358.3,24315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24315,1,3,0)
 ;;=3^Hypertensive Heart Disease w/o Heart Failure
 ;;^UTILITY(U,$J,358.3,24315,1,4,0)
 ;;=4^I11.9
 ;;^UTILITY(U,$J,358.3,24315,2)
 ;;=^5007064
 ;;^UTILITY(U,$J,358.3,24316,0)
 ;;=I12.0^^82^1052^5
 ;;^UTILITY(U,$J,358.3,24316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24316,1,3,0)
 ;;=3^Hypertensive CKD w/ Stage 5 CKD or ESRD
 ;;^UTILITY(U,$J,358.3,24316,1,4,0)
 ;;=4^I12.0
 ;;^UTILITY(U,$J,358.3,24316,2)
 ;;=^5007065
 ;;^UTILITY(U,$J,358.3,24317,0)
 ;;=I12.9^^82^1052^4
 ;;^UTILITY(U,$J,358.3,24317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24317,1,3,0)
 ;;=3^Hypertensive CKD w/ Stage 1-4 CKD
 ;;^UTILITY(U,$J,358.3,24317,1,4,0)
 ;;=4^I12.9
 ;;^UTILITY(U,$J,358.3,24317,2)
 ;;=^5007066
 ;;^UTILITY(U,$J,358.3,24318,0)
 ;;=I13.0^^82^1052^8
 ;;^UTILITY(U,$J,358.3,24318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24318,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 1-4 CKD
 ;;^UTILITY(U,$J,358.3,24318,1,4,0)
 ;;=4^I13.0
 ;;^UTILITY(U,$J,358.3,24318,2)
 ;;=^5007067
 ;;^UTILITY(U,$J,358.3,24319,0)
 ;;=I13.10^^82^1052^10
 ;;^UTILITY(U,$J,358.3,24319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24319,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 1-4 CKD
 ;;^UTILITY(U,$J,358.3,24319,1,4,0)
 ;;=4^I13.10
 ;;^UTILITY(U,$J,358.3,24319,2)
 ;;=^5007068
 ;;^UTILITY(U,$J,358.3,24320,0)
 ;;=I13.11^^82^1052^11
 ;;^UTILITY(U,$J,358.3,24320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24320,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 5 CKD/ESRD
 ;;^UTILITY(U,$J,358.3,24320,1,4,0)
 ;;=4^I13.11
 ;;^UTILITY(U,$J,358.3,24320,2)
 ;;=^5007069
 ;;^UTILITY(U,$J,358.3,24321,0)
 ;;=I13.2^^82^1052^9
 ;;^UTILITY(U,$J,358.3,24321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24321,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 5 CKD/ESRD
